The effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO

被引:9
|
作者
Yazici, Ozan [1 ]
Ozdemir, Nuriye [2 ]
Duran, Ayse Ocak [3 ]
Menekse, Serkan [4 ]
Ali, Mehmet
Sendur, Nahit [2 ]
Karaca, Halit [3 ]
Goksel, Gamze [4 ]
Arpaci, Erkan [5 ]
Hacibekiroglu, Ilhan [6 ]
Bilgetekin, Irem [7 ]
Kacan, Turgut [8 ]
Ozkan, Metin [3 ]
Aksoy, Sercan [1 ,9 ]
Aksoy, Asude
Cokmert, Suna [10 ]
Uysal, Mukremin [11 ]
Elkiran, Emin Tamer [9 ]
Cicin, Irfan
Buyukberber, Suleyman [7 ]
Zengin, Nurullah [1 ]
机构
[1] Ankara Numune Training & Res Hosp, Dept Med Oncol, TR-06410 Ankara, Turkey
[2] Yildirim Beyazit Univ, Fac Med, Dept Med Oncol, TR-06800 Ankara, Turkey
[3] Erciyes Univ, Fac Med, Dept Med Oncol, TR-38030 Kayseri, Talas Melikgazi, Turkey
[4] Celal Bayar Univ, Fac Med, Dept Med Oncol, TR-45030 Uncubozkoy, Manisa, Turkey
[5] Sakarya Univ, Educ & Res Hosp, Dept Med Oncol, TR-54100 Sirinevler, Sakarya, Turkey
[6] Trakya Univ, Fac Med, Dept Med Oncol, TR-22050 Karaagac, Edirne, Turkey
[7] Gazi Univ, Fac Med, Dept Med Oncol, TR-06560 Emniyet, Ankara, Turkey
[8] Cumhuriyet Univ, Fac Med, Dept Med Oncol, TR-58140 Sivas, Imaret, Turkey
[9] Inonu Univ, Fac Med, Dept Med Oncol, TR-44000 Malatya, Centre, Turkey
[10] Izmir Kent Hosp, Dept Med Oncol, Izmir, Turkey
[11] Afyon Kocatepe Univ, Fac Med, Afyon, Turkey
关键词
advanced gastric cancer; gastrectomy; resection; survival; RENAL-CELL CARCINOMA; PALLIATIVE GASTRECTOMY; CYTOREDUCTIVE NEPHRECTOMY; PLUS FLUOROURACIL; PHASE-III; RESECTION; CISPLATIN; SURGERY; CHEMOTHERAPY; EXPERIENCE;
D O I
10.2217/fon.15.304
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To investigate the role of surgical resection of primary tumor on overall survival (OS) in advanced gastric cancer patients at the time of diagnosis. Patients & methods: The survival rates of metastatic gastric cancer patients whose gastric primary tumor was resected at time of diagnosis were compared with metastatic gastric cancer patients whose primary tumor was nonresected. Results: The median progression-free survival and OS in operated and nonoperated group were 10 versus 6, 14 versus 9 months, respectively (p < 0.001). In multivariate analysis, gastric resection of primary tumor, Eastern Cooperative Oncology Group performance status, second-line chemotherapy had a significant effect on OS (hazard ratio [HR]: 0.52 [95% CI: 0.38-0.71], HR: 0.57 [95% CI: 0.42-0.78], HR: 1.48 [1.09-2.01]; p <= 0.001, p = 0.001 and p = 0.012, respectively). Conclusion: Subpopulations of patients with metastatic gastric cancer might benefit from surgical removal of primary tumor.
引用
收藏
页码:343 / 354
页数:12
相关论文
共 50 条
  • [21] Survival benefits of gastrectomy in gastric cancer patients with stage IV: a population-based study
    He, Xingkang
    Lai, Sanchuan
    Su, Tingting
    Liu, Yangyang
    Ding, Yue
    Quan, Sheng
    Si, Jianmin
    Sun, Leimin
    [J]. ONCOTARGET, 2017, 8 (63) : 106577 - 106586
  • [22] Effects of age on survival and morbidity in gastric cancer patients undergoing gastrectomy
    Yoshinori Fujiwara
    Shuichi Fukuda
    Masanori Tsujie
    Hajime Ishikawa
    Kotaro Kitani
    Keisuke Inoue
    Masao Yukawa
    Masatoshi Inoue
    [J]. World Journal of Gastrointestinal Oncology, 2017, (06) : 257 - 262
  • [23] Metformin and its impact on gastric cancer patients survival after gastrectomy
    Lee, C. K.
    Jung, M. K.
    Jung, I. K.
    Heo, S. J.
    An, J. Y.
    Kim, H. I.
    Chung, J. H.
    Hyung, W. J.
    Noh, S. H.
    Kim, H. S.
    Rha, S. Y.
    Chung, H. C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 20 - 20
  • [24] Survival Benefit of Palliative Gastrectomy in Gastric Cancer Patients with Peritoneal Metastasis
    Tokunaga, Masanori
    Terashima, Masanori
    Tanizawa, Yutaka
    Bando, Etsuro
    Kawamura, Taiichi
    Yasui, Hirofumi
    Boku, Narikazu
    [J]. WORLD JOURNAL OF SURGERY, 2012, 36 (11) : 2637 - 2643
  • [25] Survival Benefit of Palliative Gastrectomy in Gastric Cancer Patients with Peritoneal Metastasis
    Masanori Tokunaga
    Masanori Terashima
    Yutaka Tanizawa
    Etsuro Bando
    Taiichi Kawamura
    Hirofumi Yasui
    Narikazu Boku
    [J]. World Journal of Surgery, 2012, 36 : 2637 - 2643
  • [26] Effects of age on survival and morbidity in gastric cancer patients undergoing gastrectomy
    Fujiwara, Yoshinori
    Fukuda, Shuichi
    Tsujie, Masanori
    Ishikawa, Hajime
    Kitani, Kotaro
    Inoue, Keisuke
    Yukawa, Masao
    Inoue, Masatoshi
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 9 (06) : 257 - 262
  • [27] Palliative Gastrectomy and Metastasectomy is Associated with Improved Survival in Metastatic Gastric Cancer: An Analysis of the National Cancer Database
    Chao, J. C.
    Greco, S. H.
    Heath, N. G.
    Lin, Y.
    Peng, S.
    Gall, V. A.
    Grandhi, M. S.
    Kennedy, T.
    Carpizo, D. R.
    Alexander, H. R.
    Langan, R. C.
    August, D. A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S90 - S90
  • [28] Comparison of Clinical Outcomes of Gastrojejunal Bypass and Gastrectomy in Patients With Metastatic Gastric Cancer
    Matsubara, Daiki
    Konishi, Hirotaka
    Kubota, Takeshi
    Kosuga, Toshiyuki
    Shoda, Katsutoshi
    Shiozaki, Atsushi
    Fujiwara, Hitoshi
    Okamoto, Kazuma
    Otsuji, Eigo
    [J]. ANTICANCER RESEARCH, 2019, 39 (05) : 2545 - 2551
  • [29] Role of Metastasectomy on Overall Survival of Patients with Metastatic Gastric Cancer
    Yang, Seung Wook
    Kim, Min Gyu
    Lee, Ju Hee
    Kwon, Sung Joon
    [J]. JOURNAL OF GASTRIC CANCER, 2013, 13 (04) : 226 - 231
  • [30] Is there a role for palliative gastrectomy in asymptomatic metastatic gastric cancer?
    Musettini, G.
    Caparello, C.
    Pasquini, G.
    Vivaldi, C.
    Lencioni, M.
    Petrini, I.
    Fabrini, M. G.
    Pallabazzer, G.
    D'Imporzano, S.
    Solito, B.
    Santi, S.
    Fornaro, L.
    Vasile, E.
    Falcone, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S460 - S461